Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.

@article{Allgulander2007PharmacotherapyOG,
  title={Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.},
  author={Christer Allgulander and James M Hartford and James Russell and Susan D. Stewart Ball and Janelle Shannon Erickson and Joel Raskin and Moira A Rynn},
  journal={Current medical research and opinion},
  year={2007},
  volume={23 6},
  pages={1245-52}
}
OBJECTIVE Duloxetine is a serotonergic noradrenergic reuptake inhibitor with demonstrated efficacy in each of three independent studies for treatment of adults with generalized anxiety disorder (GAD). A pooled dataset from all completed trials is provided here to show the most likely clinical outcomes associated with duloxetine treatment for GAD. RESEARCH DESIGN AND METHODS Data were summed at the individual patient level from three double-blind, placebo-controlled trials of duloxetine… CONTINUE READING